Publications

Review Articles

Original Research articles

Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation.

Cancer Research, May 2017

Moran B, Rahman A, Palonen K, Lanigan FT, Gallagher WM.

Link to article


Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy

Clinical Chemistry, April 2017

Duffy MJ, McDermott EW, Crown J.

Link to article


Vitamin D analogues: Potential use in cancer treatment.

Critical Reviews in Oncology/Hematology, April 2017

Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J

Link to article


Interrogating open issues in cancer precision medicine with patient-derived xenografts

Nature Reviews Cancer, April 2017

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L

Link to article


Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

European Journal of Cancer, April 2017

Duffy MJ, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, Cardoso F

Link to article



MicroRNA Profiling of Exosomes

Methods in Molecular Biology, January 2017

Daly M, O’Driscoll L
Link to article

Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation

Cancer Research, May 2017

Moran B, Rahman A, Palonen K, Lanigan FT, Gallagher WM.

Link to article


Circulating microRNAs in Cancer

Methods in Molecular Biology, November 2016

O’Brien KP, Ramphul E, Howard L, Gallagher WM, Malone C, Kerin MJ, Dwyer RM

Link to article


Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray Technology

Methods Molecular Biology, October 2016

Mulrane L, Gallagher WM, O’Connor DP.

Link to article


The ADAMs family of proteases as targets for the treatment of cancer.

Cancer Biology Therapy, August 2017

Mullooly M, McGowan PM, CrownJ, Duffy MJ

Link to article


Validated biomarkers: The key to precision treatment in patients with breast cancer

The Breast, August 2016

Duffy MJ, O’Donovan N, McDermott E, Crown J.

Link to article



Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer

International Journal of Cancer, May 2016

Joyce DP,=Kerin MJ, Dwyer RM

Link to article


Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.

Expert Review of Molecular Diagnostics, May 2016

Walsh L, Gallagher WM, O’Connor DP, Ní Chonghaile T

Link to article


Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.

ASC Nano, March 2016

Fais S, O’Driscoll L, Borras FE, Buzas E, Camussi G, Cappello F, Carvalho J, Cordeiro da Silva A, Del Portillo H, El Andaloussi S, Ficko Trček T, Furlan R, Hendrix A, Gursel I, Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka ME, Lipps G, Logozzi M, Marcilla A, Sammar M, Llorente A, Nazarenko I, Oliveira C, Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, van Niel G, Vasconcelos MH, Yáñez-Mó M, Yliperttula ML, Zarovni N, Zavec AB, Giebel B

Link to article


Beyond the exome: the role of non-coding somatic mutations in cancer.

Annals of Oncology, February 2016

Piraino SW, Furney SJ.

Link to article


TMetabolic syndrome – a closer look at the growing epidemic and its consequences.

Obesity Reviews, January 2015

O’Neill S, O’Driscoll L.

Link to article


Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.
Clinical Chemistry, March 2015

Martinez VG, O’Driscoll L.

Link to article


Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.

American Journal of Epidemiology, May 2015

Mischak H, Critselis E, Hanash S, Gallagher WM, Vlahou A, Ioannidis JP.

Link to article


Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers.

Clinical Chemistry, June 2015


Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM.

Link to article


Expanding on exosomes and ectosomes in cancer.

New England Journal of Medicine, June 2015


O’Driscoll L.

Link to article



Biomarkers in Breast Cancer: Where Are We and Where Are We Going?

Advanced Clinical Chemistry, June 2015


Duffy MJ, Walsh S, McDermott EW, Crown J.

Link to article


IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance

Frontiers in Endocrinology, July 2015


Cox OT, O’Shea S, Tresse E, Bustamante-Garrido M, Kiran-Deevi R, O’Connor R.

Link to article


The Role of Exosomes in Breast Cancer.

Clinical Chemistry, December 2015

Lowry MC, Gallagher WM, O’Driscoll L.

Link to article


PRC2 mediated H3K27 methylations in cellular identity and cancer

Current Opinion Cell Biology, December 2015

Conway E, Healy E, Bracken AP.

Link to article

uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.

Breast Cancer Research, August 2014

Duffy MJ, McGowan PM, Harbeck N, Thomssen C, Schmitt M.

Link to article


A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.

Breast Cancer Research, November 2014

Mulrane L, Gallagher WM, O’Connor DP.

Link to article


p53 as a target for the treatment of cancer.

Cancer Treatment Reviews, December 2014

Duffy MJ, Synnott NC, McGowan PM, Crown J, O’Connor D, Gallagher WM.

Link to article


Metabolic syndrome – a closer look at the growing epidemic and its consequences.

Obesity Reviews, January 2015

O’Neill S, O’Driscoll L.

Link to article

miRNA dysregulation in breast cancer.

Breast Cancer Research, 2015, October 2013

Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O’Connor JP, O’Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM.

Link to article


Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer

International Journal of Cancer, June 2017

Martinez VG, Crown J, Porter RK, O’Driscoll L

Link to article


Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

BMC Medicine, June 2017

Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T, Joseph J, Dynoodt P, Aura C, Foth M, Cloots R, van den Hurk K, Balint B, Murphy IG, McDermott EW, Sheahan K, Jirström K, Nodin B, Mallya-Udupi G, van den Oord JJ, Gallagher WM, Esteller M

Link to article


Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells

International Journal of Oncology, June 2017

McDermott MSJ, Canonici A, Ivers L, Browne BC, Madden SF, O’Brien NA, Crown J, O’Donovan N.

Link to article


Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach

Oncotarget, May 2017

Moran B, Das S, Smeets D, Peutman G, Klinger R, Fender B, Connor K, Ebert M, Gaiser T, Prehn JH, Bacon O, Kay E, Hennessy B, Murphy V, Ylstra B, Lambrechts D, Byrne AT, Gallagher WM, O’Connor DP.

Link to article


Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

JAMA Oncology, May 2017

Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, Oesterreich S, Brufsky AM, Young L, Lee AV.

Link to article


Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib resistant breast cancer models

PLoS One, May 2017

Santra T, Roche S, Conlon N, O’Donovan N, Crown J, O’Connor R, Kolch W

Link to article


Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

Cancer Research. April 2017

Li B, Ni Chonghaile T, Fan Y, Madden SF, Klinger R, O’Connor AE, Walsh L, O’Hurley G, Mallya Udupi G, Joseph J, Tarrant F, Conroy E, Gaber A, Chin SF, Bardwell HA, Provenzano E, Crown J, Dubois T, Linn S, Jirstrom K, Caldas C, O’Connor DP, Gallagher WM.

Link to article


Vitamin D receptor as a target for breast cancer therapy

Endocrine Related Cancer, April 2017

Murray A, Madden SF, Synnott NC, Klinger R, O’Connor D, O’Donovan N, Gallagher W, Crown J, Duffy MJ.

Link to article



S100β as a serum marker in endocrine resistant breast cancer

BMC Medicine, April 2017

Charmsaz S, Hughes É, Bane FT, Tibbitts P, McIlroy M, Byrne C, Cocchiglia S, McBryan J, Hennessy BT, Dwyer RM, Kerin MJ, Hill AD, Young LS

Link to article


EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

Nature Methods, February 2017
Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, Berx G, Boere J, Boukouris S, Bremer M, Buschmann D, Byrd JB, Casert C, Cheng L, Cmoch A, Daveloose D, De Smedt E, Demirsoy S, Depoorter V, Dhondt B, Driedonks TA, Dudek A, Elsharawy A, Floris I, Foers AD, Gärtner K, Garg AD, Geeurickx E, Gettemans J, Ghazavi F, Giebel B, Kormelink TG, Hancock G, Helsmoortel H, Hill AF, Hyenne V, Kalra H, Kim D, Kowal J, Kraemer S, Leidinger P, Leonelli C, Liang Y, Lippens L, Liu S, Lo Cicero A, Martin S, Mathivanan S, Mathiyalagan P, Matusek T, Milani G, Monguió-Tortajada M, Mus LM, Muth DC, Németh A, Nolte-‘t Hoen EN, O’Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau Q, Sahoo S, Sampaio N, Samuel M, Scicluna B, Soen B, Steels A, Swinnen JV, Takatalo M, Thaminy S, Théry C, Tulkens J, Van Audenhove I, van der Grein S, Van Goethem A, van Herwijnen MJ, Van Niel G, Van Roy N, Van Vliet AR, Vandamme N, Vanhauwaert S, Vergauwen G, Verweij F, Wallaert A, Wauben M, Witwer KW, Zonneveld MI, De Wever O, Vandesompele J

Link to article


Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4

British Journal of Cancer, February 2017

Breslin S*, Lowry M*, O’Driscoll L

Link to article

Identification of coding and non-coding mutational hotspots in cancer genomes

BMC Genomics, January 2017

Piraino SW, Furney SJ

Link to article


Screening of exosomal microRNAs from colorectal cancer cells

Cancer Biomarkers, January 2017

Cillian Clancy, Sonja Khan, Claire L Glynn, Emma Holian, Peter Dockery, Pierce Lalor, James A.L Brown, Myles R Joyce, Michael J Kerin, Roisin M Dwyer

Link to article


Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life.

Supportive Care in Cancer, January 2017

Smith A, Murphy L, Bennett K, Barron TI

Link to article


Integrating network reconstruction with mechanistic modelling to predict potential cancer therapy

Science Signalling, November 2016

Halasz M, Kholodenko BN, Kolch W, Santra T

Link to article


BGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer research

Scientific Reports, November 2016

Martinez LI, Kolch W, Santra T

Link to article


The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.

Oncotarget, October 2016

Toomey S, Madden SF, Furney SJ, Fan Y, McCormack M, Stapleton C, Cremona M, Cavalleri GL, Milewska M, Elster N, Carr A, Fay J, Kay EW, Kennedy S, Crown J, Gallagher WM, Hennessy BT, Eustace AJ.

Link to article


Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?

International Journal of Cancer, September 2016

Synnott NC, Murray A, McGowan PM, Kiely M, Kiely PA, O’Donovan N, O’Connor DP, Gallagher WM, CrownJ, Duffy MJ

Link to article


De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer.

British Journal of Cancer, August 2016

Smith A, Murphy L, Sharp L, O’Connor D, Gallagher WM, Bennett K, Barron TI

Link to article


AKT1(E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection

BMC Medicine, August 2016

Rudolph M, Anzeneder T, Schulz A, Beckmann G, Byrne AT, Jeffers M, Pena C, Politz O, Köchert K, Vonk R, Reischl J.

Link to article


A Bayesian algorithm for detecting differentially expressed proteins and its application in breast cancer research

Scientific Reports. July 2016

Santra T, Delatola EI

Link to article


RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Journal National Cancer Institute, July 2016

Toomey S, Eustace AJ, Pritzker LB, Pritzker KP, Fay J, O’Grady A, Cummins R, Grogan L, Kennedy J, O’Connor D, Young L, Kay EW, O’Donovan N, Gallagher WM, Kalachand R, Crown J, Hennessy B

Link to article


The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.

Oncotarget, June 2016

Breslin S & O’Driscoll L

Link to article


Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells.

Endocrine Related Cancers, April 2016
Caiazza F, Murray A, Madden SF, Synnott NC, Ryan EJ, O’Donovan N, Crown J, Duffy MJ.

Link to article


Lysosome triggered near-infrared fluorescence imaging of cellular trafficking processes in real time.

Nature Communications, March 2016

Grossi M, Morgunova M, Cheung S, Scholz D, Conroy E, Terrile M, Panarella A, Simpson JC, Gallagher WM, O’Shea DF.

Link to article


AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cell.

Biochimica et Biophysica Acta (BBA), April 2016

Antonietti P, Gessler F, Düssmann H, Reimertz C, Mittelbronn M, Prehn JH, Kögel D.

Link to article


Adaptation to AI therapy in breast cancer can induce dynamic alterations in ER activity resulting in estrogen independent metastatic tumours.

Clinical Cancer Research, January 2016

Varešlija D, McBryan J, Fagan A, Redmond AM, Hao Y, Sims AH, Turnbull A, Dixon JM, Ó Gaora P, Hudson L, Purcell S, Hill AD, Young LS.

Link to article


Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Scientific Reports, January 2016

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR,Gaber A, O’Hurley G, Lehn S, Muris JJ3, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O’Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Link to article

Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.

Clinical Cancer Research, December, 2015

McBryan J, Fagan A, McCartan D, Bane FT, Varešlija D, Cocchiglia S, Byrne C, Bolger J, McIlroy M, Hudson L, Tibbitts P, O Gaora PO, Hill AD, Young LS.

Link to article


A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence.

Gene and Development, October 2015

Brien GL, Healy E, Jerman E1, Conway E, Fadda E, O’Donovan D, Krivtsov AV, Rice AM, Kearney CJ, Flaus A, McDade SS, Martin SJ, McLysaght A, O’Connell DJ, Armstrong SA, Bracken AP.

Link to article


miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.

Oncotarget, September 2015

O’Brien K, Lowry MC, Corcoran C, Martinez VG, Daly M, Rani S, Gallagher WM, Radomski MW, MacLeod RA, O’Driscoll L.

Link to article


Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

FEBS Journal, July 2015


ALanigan F, Brien GL, Fan Y, Madden SF, Jerman E, Maratha A, Aloraifi F, Hokamp K, Dunne EJ, Lohan AJ, Flanagan L, Garbe JC, Stampfer MR, Fridberg M, Jirstrom K, Quinn CM, Loftus B, Gallagher WM, Geraghty J, Bracken AP.

Link to article


De-novo post-diagnosis aspirin use and mortality in women with stage I-III breast cancer.

Cancer Epidemiology, Biomarkers and Prevention, June 2015


Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L.

Link to article


MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.

BMC Cancer, May 2015


Khan S, Wall D, Curran C, Newell J, Kerin MJ and Dwyer RM.

Link to article


Targeting ADAM-17 with an Inhibitory Monoclonal Antibody Has Anti-tumor Effects in Triple-negative Breast Cancer Cells.

British Journal of Cancer, June 2015


Caiazza F, McGowan P, Mullooly M, Murray A, Synnott N, O’Donovan N, Flanagan L, Tape CJ, Murphy G, Crown J, Duffy MJ.

Link to article

Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I-III Breast Cancer: A Nationwide Population-Based Cohort Study.

Cancer Research, August 2014

Barron, T. I., Flahavan, E. M., Sharp, L., Bennett, K., and Visvanathan, K.

Link to article


Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer

Breast Cancer Research, July 2014

O’Leary, P.C.; Terrile, M., Bajor, M., Gaj, P., Hennessy, B. T., Mills, G. B., Zagozdzon, A., O’Connor, D.P., Brennan, D. J., Connor, K., Li, J.; Gonzalez-Angulo, A. M.; Sun, H. D.; Pu, J. X.; Ponten, F.; Uhlen, M.; Jirstrom, K.; Nowis, D. A.; Crown, J. P.; Zagozdzon, R.; Gallagher, W. M.

Link to article


Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.

Neoplasia, July 2014

Rani, S., Corcoran, C., Shiels, L., Germano, S., Breslin, S., Madden, S., McDermott, M. S., Browne, B. C., O’Donovan, N., Crown, J., Gogarty, M.; Byrne, A. T. and O’Driscoll, L.
Link to article


Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the beta1-integrin-RhoA signaling axis.

Neoplasia, June 2014

Deevi, R. K., Cox, O. T., and O’Connor, R.

Link to article


PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.

Molecular Cancer, June 2014

McDermott, M. S., Browne, B. C., Conlon, N. T., O’Brien, N. A., Slamon, D. J., Henry, M., Meleady, P., Clynes, M., Dowling, P., Crown, J., and O’Donovan, N

Link to article


Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.

Cancer Research, March 2014

Walsh C, Bolger J, Byrne C, Cocchiglia S, Hao Y, Fagan A, Qin Li, Cahalin A, McCartan D, McIlroy M, Ó Gaora P, Xu J, Hill AD, Young LS

Link to article


miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Molecular Cancer, March 2014

Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O’Driscoll L

Link to article


Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer.

Oncogene, January 2014

Collins DC, Cocchiglia S, Tibbitts P, Solon G, Bane FT, McBryan J, Treumann A, Eustace A, Hennessy B, Hill AD, Young LS

Link to article

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

EMBO Molecular Medicine, December 2013

Romagnoli M, Mineva ND, Polmear M, Conrad C, Srinivasan S, Loussouarn D, Barillé-Nion S, Georgakoudi I, Dagg A, McDermott EW, Duffy MJ, McGowan PM, Schlomann U, Parsons M, Bartsch JW, Sonenshein GE

Link to article


Investigation of molecular alteration of AKT-3 in triple negative breast cancer.

Histopathology, December 2013

O’Hurley G, Daly E, O’Grady A, Cummins R, Quinn C, Flanagan L, Pierce A, Fan Y, Lynn MA, Rafferty M, Fitzgerald D, Pontén F, Duffy MJ, Jirström K, Kay EW, Gallagher WM

Link to article


Correlating transcriptional networks to breast cancer survival: a large scale coexpression analysis.

Carcinogenesis, October 2013

Clarke C, Madden SF, Doolan P, Aherne ST, Joyce H, O’Driscoll L, Gallagher WM, Hennessy BT

Link to article


Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer.

Oncotargets, October 2013

Canonici A, Gijsen M, Mullooly M, Bennett R, Bouguern N, Pedersen K, O’Brien NA, Roxanis I, Li JL, Bridge E, Finn R, Siamon D, McGowan P, Duffy MJ, O’Donovan N, Crown J, Kong A.

Link to article

Research raises hopes for new breast cancer treatment rte.ie/news/2017/0717… via @rte

About 4 days ago from BREAST-PREDICT's Twitter via Twitter Web Client

Our Partners